Heterogeneity of Monoclonal Antibodies(13)

study of monoclonal antibody stability.Pharm Res 7:1234–1241.

22.Rao P,Williams A,Baldwin-Ferro A,Hanigan E,

Kroon D,Makowski M,Meyer E,Numsuwan V, Rubin E,Tran A.1991.C-Terminal Modification occurs in tissue culture produced OKT.Bio Pharm 4:38–43.

23.Mimura Y,Nakamura K,Takeo K.1992.Analysis

of the interaction between an alpha(1—6) dextran-specific mouse hybridoma antibody and dextran B512by affinity electrophoresis.J Chro-matogr597:345–350.

24.Mimura Y,Kabat EA,Tanaka T,Fujimoto M,

Takeo K,Nakamura K.1995.Microheterogeneity of mouse antidextran monoclonal antibodies.Elec-trophoresis16:116–123.

25.Mimura Y,Nakamura K,Tanaka T,Fujimoto M.

1998.Evidence of intra-and extracellular modifi-cations of monoclonal IgG polypeptide chains gen-erating charge heterogeneity.Electrophoresis19: 767–775.

26.Perkins M,Theiler R,Lunte S,Jeschke M.2000.

Determination of the origin of charge heterogene-ity in a murine monoclonal antibody.Pharm Res 17:1110–1117.

27.Janini G,Saptharishi N,Waselus M,Soman G.

2002.Element of a validation method for MU-B3 monoclonal antibody using an imaging capillary isoelectric focusing system.Electrophoresis23: 1605–1611.

28.Schmelzer AE,Miller WM.2002.Hyperosmotic

stress and elevated pCO2alter monoclonal anti-body charge distribution and monosaccharide con-tent.Biotechnol Prog18:346–353.

29.Moorhouse KG,Nashabeh W,Deveney J,Bjork

NS,Mulkerrin MG,Ryskamp T.1997.Validation of an HPLC method for the analysis of the charge heterogeneity of the recombinant monoclonal anti-body IDEC-C2B8after papain digestion.J Pharm Biomed Anal16:593–603.

30.Hunt G,Hotaling T,Chen AB.1998.Validation

of a capillary isoelectric focusing method for the recombinant monoclonal antibody C2B8.J Chro-matogr A800:355–367.

31.Costello MA,Woitttz C,De Feo J,Stremlo D,Wen

LL,Palling DJ,Iqbal K,Guzman NA.1992.Char-acterization of humanized anti-Tac monoclonal antibody by traditional separation techniques and capillary electrophoresis.J Liq Chromatogr 15:1081–1097.

32.Tsai PK,Bruner MW,Irwin JI,Ip CC,Oliver CN,

Nelson RW,Volkin DB,Middaugh CR.1993.Ori-gin of the isoelectric heterogeneity of monoclonal immunoglobulin h1B.Pharm Res10:1580–1586.

33.Robinson DK,Chan CP,Yu lp C,Tsai PK,Tung J,

Seamans TC,Lenny AB,Lee DK,Irwin J,Silberk-lang M.1994.Characterization of a recombinant

antibody produced in the cource of a high yield Fed-batch process.Biotechnol Bioeng44:727–735.

34.Weitzhandler M,Farnan D,Horvath J,Rohrer JS,

Slingsby RW,Avdalovic N,Pohl C.1998.Protein variant separations by cation-exchange chromato-graphy on tentacle-type polymeric stationary phases.J Chromatogr A828:365–372.

35.Weitzhandler M,Farnan D,Rohrer JS,Avdalovic

N.2001.Protein variant separations using cation exchange chromatography on grafted,polymeric stationary phases.Proteomics1:179–185.

36.Santora LC,Krull IS,Grant K.1999.Character-

ization of recombinant human monoclonal tissue necrosis factor-alpha antibody using cation-exchange HPLC and capillary isoelectric focusing.

Anal Biochem275:98–108.

37.Santora LC,Kaymakcalan Z,Sakorafas P,Krull

IS,Grant K.2001.Characterization of noncova-lent complexes of recombinant human monoclonal antibody and antigen using cation exchange,size exclusion chromatography,and BIAcore.Anal Bio-chem299:119–129.

38.Santora LC,Stanley K,Krull IS,Grant K.2006.

Characterization of maleuric acid derivatives on transgenic human monoclonal antibody due to post-secretional modifications in goat milk.

Biomed Chromatogr20:843–856.

39.Hunt G,Moorhouse KG,Chen AB.1996.Capillary

isoelectric focusing and sodium dodecyl sulfate-capillary gel electrophoresis of recombinant huma-nized monoclonal antibody H ER2.J Chromatogr A744:295–301.

40.Harris RJ,Kabakoff B,Macchi FD,Shen FJ,

Kwong M,Andya JD,Shire SJ,Bjork N,Totpal K,Chen AB.2001.Identification of multiple sources of charge heterogeneity in a recombinant antibody.J Chromatogr B Biomed Sci Appl752: 233–245.

41.Zhang W,Czupryn MJ.2003.Analysis of isoas-

partate in a recombinant monoclonal antibody and its charge isoforms.J Pharm Biomed Anal30: 1479–1490.

42.Dillon TM,Bondarenko PV,Rehder DS,Pipes GD,

Kleemann GR,Ricci MS.2006.Optimization of a reversed-phase high-performance liquid chroma-tography/mass spectrometry method for charac-terizing recombinant antibody heterogeneity and stability.J Chromatogr A1120:112–120.(Epub 2006Jan2030.)

43.Dillon TM,Bondarenko PV,Speed Ricci M.2004.

Development of an analytical reversed-phase high-performance liquid chromatography-electro-spray ionization mass spectrometry method for characterization of recombinant antibodies.

J Chromatogr A1053:299–305.

44.Huang L,Lu J,Wroblewski VJ,Beals JM,Riggin

RM.2005.In vivo deamidation characterization of

JOURNAL OF PHARMACEUTICAL SCIENCES,VOL.97,NO.7,JULY2008DOI10.1002/jps 2438LIU ET AL.